Clinical case of mantle cell lymphoma of the prostate

Cover Page

Cite item

Full Text

Abstract

The article presents a clinical case of mantle cell lymphoma of the prostate in a 75-year-old man who was hospitalized in the Emergency Urological Department of the City Clinical Hospital No. 52 with gross hematuria through cystostomy tube. During examination the patient was found to have prostatomegaly (prostate volume 992 cm3), prostate-specific antigen level was 2.2 ng/mL. Immunohistochemical examination of prostate tissue after adenectomy indicates prostate damage due to mantle cell lymphoma.

About the authors

R. N. Trushkin

City Clinical Hospital No. 52, Moscow Healthcare Department

Author for correspondence.
ORCID iD: 0000-0002-3108-0539

3 Pekhotnaya St., Moscow 123182

Russian Federation

E. A. Baryakh

City Clinical Hospital No. 52, Moscow Healthcare Department;
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University);
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

ORCID iD: 0000-0001-6880-9269

3 Pekhotnaya St., Moscow 123182,

Build. 2, 8 Trubetskaya St., Moscow 119991,

Build. 1, 2/3 Barrikadnaya St., Moscow 125993

Russian Federation

P. E. Medvedev

City Clinical Hospital No. 52, Moscow Healthcare Department

Email: pah95@mail.ru
ORCID iD: 0000-0003-4250-0815
SPIN-code: 3574-1823

Pavel E. Medvedev

3 Pekhotnaya St., Moscow 123182

 

Russian Federation

Yu. A. Lagoyskaya

City Clinical Hospital No. 52, Moscow Healthcare Department

ORCID iD: 0009-0007-0012-5451

3 Pekhotnaya St., Moscow 123182

Russian Federation

E. A. Semenova

City Clinical Hospital No. 52, Moscow Healthcare Department

ORCID iD: 0009-0000-5973-9326

3 Pekhotnaya St., Moscow 123182

Russian Federation

D. V. Fettser

City Clinical Hospital No. 52, Moscow Healthcare Department

ORCID iD: 0000-0002-4143-8899

3 Pekhotnaya St., Moscow 123182

Russian Federation

A. A. Chumikov

City Clinical Hospital No. 52, Moscow Healthcare Department

ORCID iD: 0009-0001-2763-464X

3 Pekhotnaya St., Moscow 123182

Russian Federation

T. K. Isaev

City Clinical Hospital No. 52, Moscow Healthcare Department

ORCID iD: 0000-0003-3462-8616

3 Pekhotnaya St., Moscow 123182

Russian Federation

References

  1. Teras L.R., DeSantis C.E., Cerhan J.R. et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Canser J Clin 2016;66(6):443–59. doi: 10.3322/caac.21357
  2. Armitage J.O., Longo D.L. Mantle cell lymphoma. N Engl J Med 2022;386(26):2495–506. doi: 10.1056/NEJMra2202672
  3. Campo E., Jaffe E.S., Cook J.R. et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 2022;140(11):1229–53. doi: 10.1182/blood.2022015851
  4. Alaggio R., Amador C., Anagnostopoulos I. et al. The 5th edition of the World Health Organisation Classification of hematolymphoid tumors: Lymphoid Neoplasms. Leukemia 2022;36(7):1720–48. doi: 10.1038/s41375-022-01620-2
  5. Olweny C.L. Cotswolds modification of the Ann Arbor staging system for Hodgkin’s disease. J Clin Oncol 1990;8(9):1598.
  6. Hoster E., Dreyling M., Klapper W. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 2008;111(2):558–6. doi: 10.1182/blood-2007-06-095331
  7. Vorobyev V.I., Tumyan G.S. Mantle cell lymphoma. Russian clinical guidelines on diagnosis and treatment of malignant lymphoproliferative diseases. Eds.: I.V. Poddubnaya, V.G. Savchenko. 2020. (In Russ.).
  8. Doshi K., Chandran A., Li Y. et al. Mantle zone lymphoma with prostate gland enlargement: a case report. Cureus 2022;14(11):e32045. doi: 10.7759/cureus.32045
  9. Dreyling M.M., Doorduijn J.K., Gine E. et al. Efficacy and safety of ibrutinib combined with standard first-line treatment or as substitute for autologous stem cell transplantation in younger patients with mantle cell lymphoma: results from the randomized triangle trial by the European MCL Network. Blood 2022;140(Suppl 1):1–3.
  10. National Comprehensive Cancer Network. Available at: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
  11. Belkacemi Y., Sio T.T., Colson-Durand L. et al. Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019. Crit Rev Oncol Hematol 2019;135:8–19. doi: 10.1016/j.critrevonc.2019.01.005
  12. Milburn P.A., Cable C.T., Trevathan S., El Tayeb M.M. Mantle cell lymphoma of the prostate gland treated with holmium laser enucleation. Proc (Bayl Univ Med Cent) 2017;30(3):338–9. doi: 10.1080/08998280.2017.11929640
  13. Karademir B., Kısa E., Özbilen M.H. et al. Unexpected hematologic malignancies after prostatectomy: case report and literature review. Urologia 2021;88(4):382–5. doi: 10.1177/0391560321993596
  14. Kumar P., Rahman K., Hussein N. et al. Primary prostatic nonHodgkin’s lymphoma presenting with features of prostatism. J Cancer Res Ther 2019;15:178–9. doi: 10.4103/jcrt.JCRT_886_16

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36986 от  21.07.2009.